Kosun Bio Co., Ltd. Share Price

Equities

A204990

KR7204990006

Food Processing

End-of-day quote Korea S.E. 5-day change 1st Jan Change
- KRW -.--% Intraday chart for Kosun Bio Co., Ltd. -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2018 9.54B 7.02M 586M Sales 2019 2.7B 1.98M 165M Capitalization 33.83B 24.9M 2.08B
Net income 2018 -59.61B -43.87M -3.66B Net income 2019 -50.11B -36.88M -3.08B EV / Sales 2018 7.52 x
Net Debt 2018 1.53B 1.13M 93.83M Net Debt 2019 5.66B 4.17M 348M EV / Sales 2019 14.7 x
P/E ratio 2018
-1.18 x
P/E ratio 2019
-0.67 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 74.3%
More Fundamentals * Assessed data
Dynamic Chart
Kosun Bio Co., Ltd. cancelled the transaction announced on September 2, 2019 CI
Kosun Bio Co., Ltd. cancelled the transaction announced on December 27, 2019 CI
Kosun Bio Co., Ltd. cancelled the transaction announced on September 5, 2019 CI
Kosun Bio Co., Ltd. cancelled the transaction announced on September 5, 2019 CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 5.39206 billion in funding from Macnica, Inc. CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 1.00000044 billion in funding CI
G2 Investment Co., Ltd. and Changkyung Jo acquired 3.13% stake in HS Vital Co., Ltd. from Korea Particle Therapy Cancer Center Co., Ltd for KRW 2 billion. CI
Korea Particle Therapy Cancer Center Co., Ltd completed the acquisition of 31.6% in HS Vital Co., Ltd. from Jiyoon Shin. CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 50 billion in funding from Korea Particle Therapy Cancer Center Co., Ltd CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 50 billion in funding CI
Korea Particle Therapy Cancer Center Co., Ltd signed a share contract to acquire 31.6% in HS Vital Co., Ltd. from Jiyoon Shin for KRW 20 billion. CI
Kosun Bio Co., Ltd. announced that it expects to receive KRW 17.306 billion in funding from Korea Particle Therapy Cancer Center Co., Ltd CI
HS Vital Co., Ltd. completed the acquisition of Afull Co., Ltd. from Ji-Yoon Shin and others. CI
HS Vital Co., Ltd. agreed to acquire Afull Co., Ltd. for KRW 74.7 billion. CI
More news
Managers TitleAgeSince
Chief Executive Officer 51 07/19/07
Comptroller/Controller/Auditor 56 07/19/07
Corporate Officer/Principal 59 -
Members of the board TitleAgeSince
Director/Board Member 69 07/19/07
Corporate Officer/Principal 59 -
Chief Executive Officer 51 07/19/07
More insiders
Kosun Bio Co., Ltd., formerly HS Vital Co., Ltd., is a Korea-based company mainly engaged in the manufacture and distribution of health functional food. Its products mainly consist of pellets and liquefied products under the brand name of balanced natural food pellet, hwangchango and others. The Company also produces functional home appliances including hydrogen water machines and cosmetics, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A204990 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW